| |
| |
|
| Insider
Information: |
Manuso James S J |
| Relationship: |
|
| City: |
Willow |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
165,146 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$146,555 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
165,146 |
|
|
| Total
Value |
$146,555 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 37.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Astex Pharmaceuticals Inc |
ASTX |
Chief Executive Office... |
2013-10-11 |
0 |
2013-10-11 |
0 |
Premium* |
|
|
RespireRx Pharmaceuticals Inc |
RSPI |
President and CEO, Dir... |
2017-09-13 |
74,252 |
2015-08-28 |
0 |
Premium* |
|
|
Ocuphire Pharma, Inc |
OCUP |
|
2024-01-01 |
90,894 |
2020-11-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OCUP |
Ocuphire Pharma, Inc |
|
• • – |
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
22,090 |
90,894 |
0 |
- |
|
| OCUP |
Ocuphire Pharma, Inc |
|
• • – |
2023-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
10,976 |
68,804 |
0 |
- |
|
| OCUP |
Ocuphire Pharma, Inc |
|
• • – |
2023-04-19 |
4 |
A |
$0.00 |
$0 |
D/D |
2,819 |
57,828 |
0 |
- |
|
| OCUP |
Ocuphire Pharma, Inc |
|
• • – |
2023-01-11 |
4 |
A |
$0.00 |
$0 |
D/D |
18,544 |
55,009 |
0 |
- |
|
| OCUP |
Ocuphire Pharma, Inc |
|
• • – |
2022-10-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
787 |
36,465 |
0 |
- |
|
| OCUP |
Ocuphire Pharma, Inc |
|
• • – |
2022-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,108 |
35,678 |
0 |
- |
|
| OCUP |
Ocuphire Pharma, Inc |
|
• • – |
2022-05-20 |
4 |
B |
$1.99 |
$9,950 |
D/D |
5,000 |
21,570 |
0.01 |
- |
|
| OCUP |
Ocuphire Pharma, Inc |
|
• • – |
2020-11-19 |
4 |
B |
$0.00 |
$0 |
D/D |
4,434 |
14,570 |
0.01 |
% |
|
| OCUP |
Ocuphire Pharma, Inc |
Director |
– • – |
2020-11-05 |
4 |
A |
$0.00 |
$0 |
D/D |
10,136 |
10,136 |
0 |
- |
|
| RSPI |
RespireRx Pharmaceuticals... |
President and CEO |
• • – |
2017-09-13 |
4 |
B |
$0.00 |
$0 |
D/D |
1,097 |
74,252 |
2.73 |
- |
|
| RSPI |
RespireRx Pharmaceuticals... |
Preident & CEO |
• • – |
2016-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
11,887,779 |
23,775,558 |
0 |
- |
|
| RSPI |
RespireRx Pharmaceuticals... |
President and CEO |
• • • |
2015-08-28 |
4 |
B |
$0.00 |
$0 |
D/D |
11,887,779 |
11,887,779 |
3.15 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2013-10-11 |
4 |
D |
$0.00 |
$0 |
I/I |
(70) |
0 |
0 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2013-10-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,900) |
0 |
0 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2013-09-04 |
4 |
OE |
$5.69 |
$42,675 |
D/D |
7,500 |
13,900 |
0 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2013-05-14 |
4 |
S |
$5.84 |
$172,280 |
D/D |
(29,500) |
6,400 |
0 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2013-05-14 |
4 |
OE |
$4.03 |
$118,885 |
D/D |
29,500 |
35,900 |
0 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2013-05-02 |
4 |
OE |
$4.03 |
$153,140 |
D/D |
38,000 |
44,400 |
0 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2013-05-02 |
4 |
S |
$5.87 |
$223,060 |
D/D |
(38,000) |
6,400 |
0 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2013-03-08 |
4 |
S |
$4.40 |
$176,000 |
D/D |
(40,000) |
6,400 |
0 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2013-03-08 |
4 |
OE |
$2.46 |
$98,400 |
D/D |
40,000 |
46,400 |
0 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
President/CEO |
• • – |
2008-03-20 |
4 |
B |
$2.29 |
$4,580 |
D/D |
2,000 |
3,400 |
2.73 |
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
President/CEO |
• • – |
2005-09-08 |
4 |
S |
$6.74 |
$87,620 |
D/D |
(13,000) |
1,400 |
|
- |
|
| ASTX |
Astex Pharmaceuticals Inc |
President/CEO |
• • – |
2005-09-08 |
4 |
OE |
$5.00 |
$65,000 |
D/D |
13,000 |
14,400 |
|
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
